Captrust Financial Advisors Palatin Technologies Inc Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.27 - $0.5 $513 - $950	1,900 Added 16.15%	13,665 $4,000
Q4 2021 Feb 14, 2022	BUY	$0.34 - $0.86 $5 - $12	15 Added 0.13%	11,765 $6,000
Q2 2020 Aug 14, 2020	BUY	$0.41 - $0.73 $4,817 - $8,577	11,750 New	11,750 $6,000
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $4,230 - $9,282	-11,750 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.75 - $0.89 $8,812 - $10,457	11,750 New	11,750 $9,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.4M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.